Payoneer, Inc. – Trademark Portfolio
Entity Type: 03
Payoneer, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 10 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include PAYONEER. The owner is based in New York, NY.
410 Park Avenue - 15th Floor
New York, NY 10022
Showing of trademarks Trademarks
Trademark Classifications
Payoneer, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Payoneer, Inc. have?
Payoneer, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 3 abandoned.
What trademark classes does Payoneer, Inc. file in?
Payoneer, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Payoneer, Inc.'s most well-known trademarks?
Payoneer, Inc.'s registered trademark portfolio includes well-known marks such as PAYONEER. These are among 7 currently registered trademarks in the portfolio.
What is Payoneer, Inc.'s trademark registration success rate?
Payoneer, Inc. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 2 applications are pending review.